Incyte Corporation

INCY

Healthcare Biotechnology

Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024.

Revenue
+14.0%
EPS
−277.9%
Free cash flow
−233.0%
Total debt
−10.5%

Quarter to September 2026, against a year earlier

121.89 0.38 −0.31%
Market cap
$24.9B
P/E
58.1×
Fwd P/E
57.3×
Dividend yield
—
F-score
9/9
ROIC
21.6%
Net debt / EBITDA
−2.2×
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
182.71 0.00 122.29 41.98 0.00 17.11 51.66 24.51 222.81 14.97
Piotroski F-Score
6 4 7 5 4 4 4 5 5 9
P/S ratio
17.39 13.44 7.18 8.69 7.11 5.42 5.20 3.96 3.37 3.75
Altman Z-Score
9.33 17.00 11.77 14.71 12.39 9.67 8.68 6.77 5.19 8.57
P/FCF ratio
104.20 0.00 51.40 29.67 0.00 28.46 19.80 32.60 60.83 14.50
Altman Z″-Score (non-manufacturers)
0.51 2.24 4.31 6.49 3.99 6.70 6.84 7.41 3.17 7.90
Beneish M-Score
(1.52) (2.08) (2.79) (2.82) (2.20) (1.98) (3.11) (2.20) (2.69) (2.43)
P/Operating CF
203.68 (231.22) 161.09 142.58 176.74 140.26 62.26 99.08 37.52 35.49
P/B ratio
45.83 12.66 7.01 7.22 7.26 4.29 4.04 2.82 4.15 3.73
EV/Sales
17.24 12.69 6.43 7.74 6.45 4.65 4.26 2.98 2.87 3.06
EV/EBITDA
93.73 0.00 65.65 36.58 0.00 21.56 22.34 15.67 80.95 9.79
EV/FCF
103.35 (95.56) 46.02 26.40 (55.17) 24.41 16.21 24.55 51.84 11.84
Current Ratio
3.64 4.01 4.31 4.83 3.74 3.65 3.54 3.75 1.97 3.32
Net Debt/EBITDA
(0.77) 5.99 (7.71) (4.53) 8.35 (3.60) (4.96) (5.16) (14.11) (2.21)
Debt/Equity
1.55 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01
ROE
35.29% (30.55%) 6.16% 19.76% (11.35%) 29.73% 8.37% 12.50% 0.76% 29.87%
ROA
7.88% (15.89%) 4.43% 14.72% (8.46%) 22.33% 6.32% 9.47% 0.53% 20.75%
ROIC
34.54% (31.37%) 15.99% 47.31% (19.56%) 25.19% 31.19% 24.81% 2.90% 58.55%
Return on Tangible Assets
11.73% (22.54%) 6.34% 19.05% (12.92%) 31.74% 9.27% 14.38% 1.38% 30.35%
Average Days of Receivables
49.11 63.27 59.66 52.21 65.97 75.33 69.34 73.44 73.42 72.73
Earnings Yield
0.55% (1.55%) 0.82% 2.38% (1.60%) 5.84% 1.94% 4.08% 0.45% 6.68%
Free Cash Flow Yield
0.96% (0.99%) 1.95% 3.37% (1.64%) 3.51% 5.05% 3.07% 1.64% 6.90%
Free Cash Flow per Share
0.98 (1.00) 1.24 2.94 (1.43) 2.58 4.02 2.01 1.14 6.81
Book value per Share
2.23 7.97 9.07 12.09 11.97 17.10 19.68 23.21 16.65 26.47
Free Cash Flow
184.48 (204.01) 262.74 632.59 (311.98) 568.48 892.11 449.00 235.17 1,329.63
EV/EBIT
131.49 0.00 93.58 41.54 0.00 23.69 24.96 17.76 198.68 10.39
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026